BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim B, Yang Q, Chan LW, Bhatia SN, Ruoslahti E, Sailor MJ. Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections. Nanoscale Horiz 2021;6:330-40. [PMID: 33599221 DOI: 10.1039/d0nh00624f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Zhou L, Qin J, Chen J, Stewart C, Sun Y, Huang H, Xu L, Li L, Han J, Li F. One-Component Multichannel Sensor Array for Rapid Identification of Bacteria. Anal Chem 2022. [PMID: 35802909 DOI: 10.1021/acs.analchem.2c02236] [Reference Citation Analysis]
2 Paul A, Muralidharan A, Biswas A, Venkatesh Kamath B, Joseph A, Alex AT. siRNA Therapeutics and its Challenges: Recent Advances in Effective Delivery for Cancer Therapy. OpenNano 2022. [DOI: 10.1016/j.onano.2022.100063] [Reference Citation Analysis]
3 Zhang X, Chen X, Zhao Y. Nanosystems for Immune Regulation against Bacterial Infections: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01380] [Reference Citation Analysis]
4 Chan LW. Advances in activity-based diagnostics for infectious disease and microbiome health. Curr Opin Biomed Eng 2021;19:100296. [PMID: 34179594 DOI: 10.1016/j.cobme.2021.100296] [Reference Citation Analysis]
5 Stoy N. Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19. Front Immunol 2021;12:638446. [PMID: 33936053 DOI: 10.3389/fimmu.2021.638446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]